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Abstract
A Schistosoma mansoni cercarial antigen preparation (cercarial transformation fluid – SmCTF) was evaluated for detection of
anti-schistosome antibodies in human sera in 4 collaborating laboratories. The performance of SmCTF was compared with
that of S. mansoni egg antigens (SmSEA) in an indirect enzyme-immunoassay (ELISA) antigen assay, the latter being used
routinely in 3 of the 4 participating laboratories to diagnose S. mansoni and S. haematobium infections. In the fourth
laboratory the performance of SmCTF was compared with that of S. japonicum egg antigens (SjSEA) in ELISA for detection of
anti-S. japonicum antibodies. In all 4 laboratories the results given by SmCTF in ELISA were very similar to those given by the
antigen preparation routinely used in the respective laboratory to detect anti-schistosome antibodies in human infection
sera. In so far as the ELISA results from SmCTF are thus so little different from those given by schistosome egg antigens and
also cheaper to produce, the former is a potentially useful new diagnostic aid for schistosomiasis.
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Introduction
More than 200 million people in over 70 countries world-wide
are infected with schistosomes with infection-induced morbidity
being particularly pronounced in sub-Saharan Africa [1,2].
Humans become infected as a result of swimming, bathing and
fishing in water in which infected intermediate host snails have
released free-swimming cercariae that can penetrate human skin.
The heaviest schistosome infections are generally found in
children and young adults and in recognition of this school
children are the main target of schistosomiasis control pro-
grammes based on treatment with praziquantel. Prior to
instigating control the prevalence and intensity of infection is
generally estimated by microscopic detection of eggs in faecal or
urine samples, which is a relatively slow and laborious process.
Insensitivity is another serious defect of egg detection methods
of diagnosis, especially of the intestinal schistosome infections [3,4]
and many light infections are missed because of the absence of
eggs in the small volumes of excreta that can be routinely
examined microscopically [5–9] These limitations impose signif-
icant constraints on current control initiatives [10,11] Consider-
able effort has been expended in the effort to develop immuno-
diagnostic tests that are an improvement on microscopical
parasitology. It has been argued that methods to detect circulating
or excreted schistosome antigens are desirable because they are
likely to reflect active infection most accurately. However, the
sensitivity of antigen detection tests seems to be no better than that
of microscopy, particularly with regard to detection of faecally-
excreted eggs of S. mansoni and in situations in which low egg
counts pertain [12,13]
Antibody detection tests have often been deemed unsuitable for
diagnosis of schistosomiasis, mainly because of their apparent lack
of specificity and inability to distinguish active from inactive
infection – namely the common observation that many subjects
that are antibody-positive are egg-negative by microscopy.
However, possible alternative explanations for the lack of
specificity are that the many instances of antibody-positivity,
egg-negativity reflect the failure of insensitive microscopy to detect
eggs in subjects who are lightly-infected [3] or who have been
treated with sub-curative drug doses [14]. Indeed it has been
demonstrated that in some patients antibody levels do decline
following treatment [15], particularly antibodies against the
soluble egg antigen fraction CEF6 and patients with more steeply
declining anti-CEF6 antibody titres were considered to have been
better cured than those with titres that remained higher [16].
There is of course also the possibility that antibody false-positives
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are due to heterologous infectious agents. Despite their failings,
antibody-detection is for some time likely to remain the best
available method for diagnosis in areas of low intensity of
schistosome infection [11,17].Tourists and other visitors to
schistosome endemic areas who become infected with schisto-
somes commonly only have light infections and because
praziquantel is such a safe drug travellers’ medicine clinics now
often base their treatment decisions on the result of an antibody-
detection diagnostic test alone. Soluble S. mansoni egg antigens
(SmSEA) in enzyme immunosorbant assay (ELISA) formats are
frequently the diagnostic method of choice in these clinics [18–20]
and such immunoassays can also give meaningful results in
endemic areas [21].
SmSEA is however a relatively expensive commodity, requiring
for its production the infection of relatively large numbers of
laboratory animals (generally mice or hamsters), from the tissues of
which the eggs are isolated after the infections become patent.
Diagnostic tests based on SmSEA would therefore not be ideal for
deployment in tropical countries with endemic schistosomiasis,
most of which are resource-poor. Based on the evidence that much
of the antibody induced by S. mansoni infections is specific for
glycanic epitopes [22,23] and that S. mansoni egg and cercarial
molecules have many glycanic epitopes in common [24–26], we
have begun to investigate whether soluble S. mansoni cercarial
antigens (in the form of a preparation we have named ‘cercarial
transformation fluid’ – SmCTF) can be substituted for SmSEA as
an antibody target in ELISA. A preliminary study has indicated
that SmCTF did indeed give very similar reactivity to SmSEA
when reacted in ELISA with sera from schistosome-infected
patients who had attended a travellers’ medicine clinic in London
[27]. In that study the sera, when tested previously, all had reacted
positively with SmSEA, but they were designated just as
schistosome-infected i.e., there was no differentiation between S.
mansoni and S. haematobium infection. There was no difference
between the rate of cross-reactivity of SmCTF with sera from
patients with other infections than that of schistosomiasis
compared to that achieved with SmSEA [27]. A second study
has also demonstrated that SmCTF performs equivalently to
SmSEA for diagnosis of S. mansoni infections in an endemic setting,
and indicates that SmCTF may actually be more specific than
SmSEA for diagnosis in endemic areas [28].In this study we have
extended that work in a collaborative study involving 3 different
parasite diagnosis laboratories in Europe: respectively, in Scotland,
England and The Netherlands, all of which deal with travellers
and immigrants from Africa or the Middle East who may be
infected with S. mansoni and/or S. haematobium. The species of
schistosome infecting many of the serum donors could be
determined by prior clinical investigations routinely carried out
in the respective laboratories, including travel history, water
exposure questionnaire and/or microscopy of urine and stools for
schistosome ova. The opportunity has also been taken to test the
reactivity of human sera from an area endemic for S. japonicum in
The People’s Republic of China.
In all 4 settings the performance of SmCTF was compared
directly with SmSEA in ELISA. In each of the four laboratories
the ‘in-house’ procedures in routine use for performing ELISA
were used to compare the antigen preparations, with therefore no
effort having been made to co-ordinate or validate the method-
ology at this stage.
Materials and Methods
Ethics statement
All the serum samples used in this study were routine diagnostic
samples which had previously been sent to the respective
laboratory from other hospitals/medical practitioners with the
request they be tested for anti-schistosome antibodies. The samples
were therefore not collected specifically for this study and were
taken from stored collections of sera.
In the case of the participating laboratory having collected the
sample for a previous routine diagnosis, sample donors were asked
if they had any objections to usage of the samples for future
research. If no objection was provided, the samples were deemed
suitable for use in this study: i.e., a determination of the merits of
different diagnostic tests.
After processing every sample sent to one of the laboratories for
testing was stored frozen in accordance with Standard Operating
Procedures for ‘‘sample collection and storage’’ that are in place in
each of the laboratories. All samples are maintained for a set
period of time in case a sample requires retesting. The collections
of sera so accrued provide reference material for research/
development studies such as this.
The S. japonicum infection sera used by Nanjing Medical
University (see below) had been collected as part of the National
Key Technologies R&D Program for China Tenth Five-Year Plan
(grant no. 2004BA718B05). The project was reviewed and
approved by the institutional review board of Nanjing Medical
University. The other 3 serum collections used in this study had
been given in-house names which were and are used in references
to them; e.g. SPDRL Sera or Amsterdam Medical Centre Serum
Bank. These were in turn parts of larger reference collections:
Scottish Parasite Clinical Reference Collection, the AMC Para-
sitology Serum Bank and the LSTM Diagnostic Parasitology
Laboratory Serum Bank.
The regulations to which the participating laboratories adhered
with regard to use of samples in their possession covered the use of
these samples in this particular study. Application for IRB
approval was deemed unnecessary and irrelevant because any
sample which was received by any of the participating laboratories
from elsewhere was given a unique identifier. No personal
Author Summary
Diagnosis of schistosomiasis is problematic since no
method is yet available that gives both 100% sensitivity
and 100% specificity. The method traditionally used is
microscopy, but because of inherent insensitivity this
technique often wrongly diagnoses patients as uninfected.
Use of serological assays involving detection of specific
antibodies is now increasing since the putative sensitivity
of these tests is much higher than that of other alternative
methods of diagnosis. They are routinely used in travellers’
medicine clinics where often only light infections are
encountered which microscopy is not sensitive enough to
detect. ELISA incorporating schistosome soluble egg
antigens (SEA) is often the antibody-detection test of
choice. The use of the SEA-ELISA for diagnosis of
schistosomiasis in developing countries is however re-
stricted since SEA is relatively expensive to produce. Here
we investigated whether a cheaper alternative S. mansoni
antigenic preparation derived from schistosome cercariae
(SmCTF) could potentially replace SEA in ELISA. Our results
demonstrate that SmCTF performs equivalently to S.
mansoni SEA for the diagnosis of both S. mansoni and S.
haematobium infections, and that SmCTF is also as good as
S. japonicum SEA for the diagnosis of schistosomiasis
japonica. We discuss how even more affordable and
practical diagnostic aids for schistosomiasis might be
developed.
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identifying data, such as name, date of birth, gender, and/or age
were retained on the collection tube. All samples were stored in
numerical order using a unique identification number to ensure
they were anonymised for any subsequent study. Each sample used
in this study was thus completely anonymised and the results were
a) not entered onto any computerised reporting system; b) not
accessible by any outside body, and c) not reported to the donor or
the sample sender and therefore not reported to the patient.
In the participating laboratories it is standard practice for stored
fully-anonymized serum samples to be used for evaluation of new
diagnostic tests, as in this study, without the need for permission to
be sought from regulatory bodies. Consent was not required for
this particular study because it was simply a comparison of
diagnostic methodologies using fully anonymised samples which
were already part of collections of reference material. Each sample
was being tested for the same parasitic infection for which it had
initially been screened. No individual’s results from this study have
been reported elsewhere and no follow-up samples were necessary.
The work on laboratory animals was approved by the Ethical
Review Procedure of the University of Nottingham. Further
details are available at this link: http://www.nottingham.ac.uk/
animalresearch/erp/erp.aspx. The work was conducted according
to the UK Animal (Scientific Procedures) act 1986 with personal
and project licence authorities held by MD (numbers PIL70/3255
and PPL40/3024 respectively). The study was conducted in
accordance to Nottingham University’s guidelines for animal
husbandry which meet the UK Home Office Code of Practice for
the Housing and Care of Animals used in Scientific Procedures.
Further details are available at this link: http://www.nottingham.
ac.uk/animalresearch/animalwelfare/animalwelfare.aspx.
Collaborating laboratories
Four medical parasitology laboratories collaborated in this study
to compare the performance of two S. mansoni antigen preparations
in ELISA with sera from schistosome-infected people: The
Scottish Parasite Diagnostic Reference Laboratory, Glasgow,
Scotland (SPDRL), The Diagnostic Parasitology Laboratory at
the Liverpool School of Tropical Medicine (LSTM), the Parasi-
tology Section, Academic Medical Center, Netherlands (AMC)
and the Department of Pathogen Biology, Nanjing Medical
University, Nanjing, China (NJMU).
Antigens
Two S. mansoni antigen preparations, SmCTF and SmSEA,
were produced by BioGlab Ltd (Nottingham, UK) and distributed
to the above-named 4 laboratories for comparison of their
performance in ELISA.
SmCTF was prepared from cercariae, the shedding of which
was induced from Biomphalaria glabrata snails. The cercariae were
shed into deionized water at 30uC under a 60 W tungsten light
and the larval suspensions concentrated by suction over a glass
fibre filter, followed by gravity-sedimentation in the dark in
approximately 20 ml water at 4uC. Excess water was removed
from over the sedimented cercarial pellets, the latter being
generally of 1 ml volume or more. The pellets were resuspended
in 5 ml phosphate buffered saline (PBS, pH 7.2) and aspirated 15
times through a 20 gauge disposable syringe needle in 5 ml
phosphate-buffered saline (pH 7.2) using a 5 ml disposable plastic
syringe [29]. Suspensions of dispersed, ‘transformed’ schistosomula
and their now separate tails were incubated in plastic Petri dishes
for 45 min at room temperature (RT). After incubation schisto-
somula and tails were removed by centrifugation (5 min, 2506 g)
and the supernatant (SmCTF) was collected and stored at 280uC.
The protein concentration of SmCTF was approximately 1.0 mg
per ml; batches were aliquoted in 1 ml volumes, freeze-dried and
distributed to the 4 collaborating laboratories for use in this study.
Extracts of S. mansoni soluble egg antigens (SmSEA) were
prepared as described earlier [30].
S. japonicum egg antigens (SjSEA) were prepared with eggs taken
from rabbits 45 days after they had been infected with
approximately 1,000 S. japonicum cercariae. Livers were removed
and kept at 4uC overnight in order to better isolate eggs. Eggs were
harvested from the homogenized livers by differential centrifuga-
tion. The absence of contaminating rabbit tissue fragments in the
egg preparation was checked by microscopic analysis. Purified
eggs were suspended in PBS and homogenized on ice. After
repeated freezing and thawing, the homogenate was centrifuged at
13,800 g at 4uC for 20 min, and the supernatant was used as S.
japonicum soluble egg antigen (SjSEA).
Antisera and enzyme-immunoassay (ELISA)
SPDRL. Antisera from 59 Officers Training Core (OTC)
pupils who visited Uganda in 2006 and swam in the White Nile
were tested. The donors were presumed to be potentially infected
with S. mansoni by virtue of this species of schistosome being
endemic in that area [31].
Antisera from 3 parasitologically-confirmed S. haematobium
travellers were also tested, as were samples from 8 Glasgow
schoolchildren who had visited Malawi for a period of 4 weeks in
2007 and who had swum in Lake Malawi, a known focus of
endemic S. haematobium [32]. The latter were thus deemed to be
potentially infected with S. haematobium.
For ELISA the wells of polystyrene, flat bottomed, duostrip
microtitre strips (Greiner; www.gbo.org) were filled with 50 ml of
carbonate-bicarbonate coating buffer (pH 9.6) containing either
2.5 mg of SmSEA protein or 2 mg SmCTF protein in 5 ml of
coating buffer, and incubated in a humidified chamber at 37uC
overnight. Excess antigens were removed by washing the wells 3
times with 250 ml of 150 mM phosphate buffered saline, pH 7.2
containing 0.05% (v/v) Tween 20 (PBS-T). Fifty ml aliquots of
human serum, diluted to 1:300 in 2.5% dried skimmed milk in
PBS-T (pH 7.2) were incubated in the coated wells at room
temperature (RT) for 30 min on a mechanical plate shaker,
followed by 3 washes with PBS-T. Fifty ml of horseradish
peroxidase-conjugated anti-human IgG (HRP-IgG; Sigma, Poole,
UK) diluted 1:900 in PBS-T were added to each well, followed by
incubation for 1 h at 37uC and washing 3 times with PBS-T.
Finally, the enzyme-substrate reaction was developed by the
addition of 50 ml of freshly prepared TMB substrate solution
(0.1 mg/ml 2, 2-azino-bis [3-ethylbenz-thiazoline-6-sulfonic acid]
containing 25 ml 30% H2O2/100 ml) to each well. The reaction
was developed for 30 min at RT and stopped by adding 50 ml of
0.18 M sulphuric acid into each well. The optical density (OD) of
each well was measured at 450 nm in a Titertek microplate reader
(Flow Laboratories, Herts., UK).
Chequer-board titrations were performed prior to analysis of
test human sera to establish the amount of each antigen to coat the
microtitre wells and the dilutions of the test sera and anti-human
IgG-peroxidase conjugate. Based on four replicates of the 50
European negative samples tested, the cut off OD450 for positive
sera, plus two standard deviations, was 0.22 for SmSEA and 0.25
for SmCTF. All antisera were tested in duplicate against both
SmSEA and SmCTF.
LSTM. Patients suspected of having schistosomiasis submitted
faecal and urine samples to the LSTM diagnostic lab. If eggs were
not found in a random urine sample patients were asked to submit
a 10am–2pm sample for membrane filtration. Faecal samples
Serodiagnosis of Schistosomiasis
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submitted for parasites were examined using a modified formol-
ether concentration, up to 3 stools/patient being tested routinely.
A total of 88 sera were examined: antisera from 40 cases of
parasitologically confirmed S. haematobium patients, seen as out-
patients at LSTM between 1995 and 2009, were tested. 18 were
travellers to Malawi and the remainder were from patients who
had lived/worked in various African countries.
The 12 antisera from parasitologically confirmed S. mansoni
patients were again referrals to LSTM, 3 were from a group who
had travelled to Namibia, 2 were co-travellers to Ethiopia and the
remainder had history of travel to Uganda and other African
countries.
Thirty six sera from ‘‘suspected’’ cases of schistosomiasis were
also tested. Patients in whom eggs had not been detected consisted
of symptomatic patients with a history of Malawi travel (13), those
with a history suggestive of exposure (swimming in African lakes),
some with blood in urine, 2 with Katayama and others presenting
with an eosiniphilia (but negative for strongyloides/filarial
antibodies). A few samples were from members of expeditions in
which other egg-positive individuals had already been found.
For ELISA flat-bottomed microtitre plates (ICN/Flow) were
coated overnight with 100 ml antigen solution (1 mg protein/ml
SmSEA or 0.8 mg protein/ml SmCTF) diluted in carbonate/
bicarbonate coating buffer, pH 9.6. Excess antigens were removed
by washing the wells 36 with 250 ml of 150 mM phosphate
buffered saline, pH 7.2 containing 0.05% (v/v) Tween 20 (PBS-T).
100 ml of each serum diluted 1/200 in PBS+1% BSA+0.1%Tween
was added to antigen-coated wells and incubated for 1 h at RT.
After each step each well was subjected to 364 min washes with
washing buffer (isotonic saline +0.5% Tween) until the substrate
was added. After washing 100 ml alkaline phosphatase-conjugated
anti-human IgG (Sigma) diluted 1:3,500 in incubation buffer
(PBS/Tween) was added for 1 hour. 100 ml liquid pNPP substrate
(Southern Biotech) was added and monitored until the OD of
negative controls reached a pre-determined OD (0.080–0.110) and
positive controls an OD .0.800 (around 30–40 minutes). ODs
were read at 405 nm on a BioRad iMark microplate reader. The
cut-off point was determined using 52 sera from control subjects
with no history of exposure to schistosomiasis. This was
determined to be 0.200 for both CTF and SEA antigens.
AMC. Antisera: a total of 41 sera were tested. The sera were
collected within 1 month of parasitological and clinical examina-
tion and stored at 220uC until use. Twenty one sera were from
patients with parasitologically proven Schistosoma infection: 10 from
patients with S. mansoni infection; 5 patients with S. haematobium
infection; and 6 patients with Katayama fever. A further 20 sera
that were positive in routine serology in the AMC hospital were
used: 9 patients positive in both IHA (Fumouze) and SEA-ELISA;
6 patients that were IHA negative, SEA-ELISA positive; and 5
patients that were IHA positive and SEA-ELISA negative. Five
sera were used as negative controls, having been found negative
after routine serological testing for presence of anti-schistosome
antibodies.
For ELISA, wells of flat-bottomed polystyrene high-bind
microplates (Corning, Inc., Acton, MA) were coated overnight at
4uC with 30 ul volumes of SmCTF (1.3 mg protein/ml) or SmSEA
(1.3 mg protein/ml) in 50 mM carbonate/bicarbonate buffer
(pH 9.6). Subsequently, the wells were treated with 30 ml PBS,
pH 7.2, containing 0.05% Tween 20 and 1% egg albumin
(PBTWEG) for 30 min at 37uC. After washing three times with
PBS containing 0.05% Tween 20 (PBTW) 30 ml of each serum
sample (diluted 1:400 in PBTWEG) were added and incubated for
1 h at 37uC. After washing five times with PBTW 30 ml
horseradish peroxidase-conjugated goat anti-human IgG (Nordic)
diluted 1:1500 in PBTWEG was added for 30 min at 37uC. The
wells were washed five times with PBTW, and 30 ml substrate
solution (0.1% 5-amino salicylic acid in phosphate buffer,
pH 5.95, with 0.03% H2O2; Merck, Whitehouse Station, NJ)
was added for 1 h in the dark at RT. The optical density (OD) was
read at 492 nm on a Multiskan Ascent reader (Labsystems,
Helsinki, Finland). The cut-off OD492 values for both SmSEA and
SmCTF was 0.22.
NMU. Sera from 42 people were collected in Jiahu village
located on the Southeastern shore of Poyang Lake, Jiangxi
Province, China. S. japonicum infection was confirmed in 25 of the
donors by detection of S. japonicum eggs in the faeces. The
remaining 17 subjects were egg-negative. Twenty sera from
volunteers without a history of residence in a schistosome-
endemic area were used as negative controls. All sera were stored
at 270uC until use.
For ELISA chequerboard titrations were performed to deter-
mine optimum antigen concentrations of SjSEA, SmSEA and
SmCTF, and the dilutions of human sera and horse radish
peroxidise(HRP)-conjugated goat anti-human IgG.
Flat-bottomed microwell plates (Costar, Corning Incorporated
Corning, New York, NY, USA) were coated overnight at 4uC with
100 ml SjSEA, SmSEA or SmCTF (all three antigens being at a
concentration of 0.2 mg protein/ml) and then washed. After
adding 200 ml blocking buffer (5% skimmed milk) in PBS (pH7.2)
the plates were incubated at 37uC for 1 h at RT and then washed.
All test sera were diluted 1:250 with PBS, and 100 ml was added to
each well. The plates were incubated at 37uC for 2 h and then
washed. HRP-conjugated goat anti-human IgG (Serotec) was
diluted 1:6000 with PBS, and 100 ml was added to each well and
incubated at 37uC for 1 h before the plates were washed. The
plates were developed with TMB substrate solution (0.2 mg/ml
2,2-azino-bis [3-ethylbenz-thiazoline-6-sulfonic acid] containing
50 ml 30% H2O2/100 ml) and the reaction stopped by adding
100 ml H2SO4 (2 M) after 15 min. The plates were read at
450 nm, using an ELISA reader (Bio-Rad mod. 550). Each serum
sample was tested in duplicate.
Statistical analysis
All data were analysed using GraphPad Prism 4 and GraphPad
InStat 3 (GraphPad Software, USA). Correlations were calculated
using either Spearman’s r correlation or Pearson’s r correlation
dependent upon the normality of the data. Sensitivities and
specificities were calculated using the SmSEA-ELISA as the ‘gold-
standard’ test unless elsewhere stated. Statistical differences in
mean SmSEA OD readings and SmCTF OD readings were
calculated using a t-test or the Wilcoxon matched pairs test as
appropriate. Statistical differences between mean OD readings of
one species compared to another were calculated using either
Welch corrected unpaired t-tests or Mann Whitney U tests.
Significance was assigned at p,0.05.
Results
SPDRL
Figure 1 shows the correlation between respective anti-SmCTF
and anti-SmSEA OD450 readings from sera of 59 school pupils
who attended a training course in the vicinity of the White Nile in
Uganda. There was 91% correlation (95% CI 85.1–94.6;
p,0.0001). It is apparent that the majority of individual anti-
SmCTF OD450 readings (mean= 0.71, SD=0.53) are greater
than the respective OD450 anti-SmSEA OD450 values
(mean=0.50, SD=0.47); a difference which is significant
(p,0.0001). The sensitivity of the SmCTF compared with the
Serodiagnosis of Schistosomiasis
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SmSEA was 97.1% and the specificity was 80%. The positive
predictive value was 86.8% and the negative predictive value was
95.3%.
Figure 2 shows the anti-SmCTF and anti-SmSEA OD450
readings for those of the 59 subjects in Figure 1 who had anti-
SmSEA ODs of between 0 and 0.3. The cut-off values for SmCTF
and SmSEA, estimated from the ELISA results of 50 negative
controls, were respectively 0.25 for SmCTF and 0.22 for SmSEA
and have been indicated in the graph. Five sera gave ODs which
were above the SmCTF cut-off, but below the SmSEA cut-off; i.e.,
recorded a positive result with the former antigen, negative with
the latter, a result consistent with SmCTF being more reactive
than SmSEA with S. mansoni infection sera in this laboratory.
Figure 3 shows individual SmCTF OD450 values plotted against
the respective SmSEA OD450 values of sera from 8 subjects known
to be infected with S. haematobium by virtue of the presence of eggs
in urine and also from 8 school children who had visited Lake
Malawi, and thereby assumed also to have been exposed to S.
haematobium. Two of the 8 children were positive for both antigens
and 6 were negative, the latter showing as a closely knit group in
the lower left corner of the figure. There was 90.8% correlation
between the SmCTF OD450 values and the SmSEA OD450 values
(95% CI 74.3–96.9; p,0.0001), and no significant difference
between their means.
Figure 4 plots the individual results of the respective anti-
SmCTF above cut-off value OD450 results from the S. mansoni-
infection sera in Figure 1 and S. haematobium-infection sera in
Figure 3. The mean of the latter values was marginally higher, but
not significantly so.
LSTM
In contrast to the results in Figure 4, LSTM found that 12 S.
mansoni infection sera gave a higher mean OD405 reading with
SmCTF than 40 S. haematobium infection sera (Figure 5), a
difference that was significant (p,0.02).
When the reactions of individual sera against SmCTF were
plotted against their respective reactions against SmSEA (Figure 6)
the anti-SmCTF OD405 values of the majority of the S. mansoni
infection sera appeared to be higher than their respective anti
SmSEA OD405 values (although this difference is not significant),
while the reactivities of the S. haematobium infection sera were
relatively evenly distributed about the equivalence line (Figure 7).
Similarly, sera from a group of subjects suspected to be infected
with schistosomes, but not determinable as either S. mansoni or S.
haematobium, reacted relatively similarly to both SmCTF and
SmSEA in ELISA (Figure 8).
For the S. mansoni infection sera, there was 88.9% correlation
between the anti-SmCTF OD405 values and the anti-SmSEA
OD405 values (95% CI 64.4–96.9; p= 0.0001). For the S.
haematobium infection sera, there was 77.4% correlation between
the anti-SmCTF OD405 values and the anti-SmSEA OD405 values
(95% CI 60.4–87.7; p,0.0001). For the suspected cases, there was
85.4% correlation (95% CI 73.4–92.2; p,0.0001).
Using either egg microscopy or the SEA-ELISA as the ‘gold-
standard’ diagnostic test, the CTF-ELISA had a sensitivity of
100% to S. mansoni infections as there were no false-negative
results. The SEA-ELISA gave one false-negative result with S.
mansoni infection sera and therefore had a sensitivity of 91.6%.
Again using egg microscopy as the ‘gold-standard’, the CTF-
ELISA had a sensitivity of 87.5% to S. haematobium infections with
5 false-negative results. Two of these were very close to the cut-off
value of 0.200 (0.198 and 0.199), and if these are taken to be
positive results sensitivity is increased to 92.5%. One of the
remaining false-negatives was with serum from a patient with
mainly calcified eggs in the urine; this serum sample also tested
negative in the SEA-ELISA. The SEA-ELISA had a sensitivity of
92.5% with 3 false-negative results. One of these false negatives
Figure 1. SPDRL: correlation between S. mansoni cercarial transformation fluid (SmCTF) and soluble egg antigen (SmSEA) in ELISA.
Results for sera from suspected S. mansoni-infected patients (59 school pupils who attended a training course in the vicinity of the White Nile in
Uganda).
doi:10.1371/journal.pntd.0001815.g001
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Figure 3. SPDRL: correlation between S. mansoni cercarial transformation fluid (SmCTF) and soluble egg antigen (SmSEA) in ELISA.
Results for sera from 8 subjects previously shown parasitologically to be infected with S. haematobium and 8 subjects suspected to be infected with S.
haematobium. m= 2 positive and 6 negative sera from patients that had visited Lake Malawi; %=patients with S. haematobium eggs in urine;
&= control positive sera from patients known to be S. haematobium-infected.
doi:10.1371/journal.pntd.0001815.g003
Figure 2. SPDRL: correlation between S. mansoni cercarial transformation fluid (SmCTF) and soluble egg antigen (SmSEA) in ELISA.
Results for sera from those subjects in Figure 1 that had anti-SmSEA OD450 values of between 0 and 0.3. Vertical and horizontal lines indicate the cut-
off values of, respectively, 0.22 for SmSEA and 0.25 for SmCTF.
doi:10.1371/journal.pntd.0001815.g002
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gave an OD reading that was close to the cut-off value (0.188).
Using the SEA-ELISA as the gold-standard test, the CTF assay
had a sensitivity of 91.9% or 97.3% if the two-values that were
close to the cut-off are taken to be positive results.
All of the sera from cases of suspected schistosomiasis gave a
positive result with at least one of the antigens in ELISA. Using
SEA in ELISA as the gold standard, the CTF-ELISA had a
sensitivity of 97% with only one false-negative result. There were
two false-positive results, which could reflect the CTF being more
sensitive than SEA.
AMC
Figure 9 shows SmCTF OD492 values plotted against the
respective SmSEA OD492 values of a total of 46 sera; 21 from
Figure 4. SPDRL: comparison of S. mansoni- and S. haematobium-infection sera in ELISA. Graph of the greater-than-cut-off OD450 results of
S. mansoni infection sera in Figure 1 and S. haematobium infection sera in Figure 2 reacting against S. mansoni cercarial transformation fluid (SmCTF).
Horizontal lines indicate the mean SmCTF OD450 values for each group of sera.
doi:10.1371/journal.pntd.0001815.g004
Figure 5. LSTM: comparison of S. mansoni- and S. haematobium-infection sera in ELISA. Reactivity of sera from S. mansoni and
S.haematobium patients against S. mansoni cercarial transformation fluid (SmCTF). Lines indicate the mean SmCTF OD405 values for each group of
sera.
doi:10.1371/journal.pntd.0001815.g005
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patients with parasitologically-proven Schistosoma infection, 20 sera
that were positive in routine serology and 5 negative controls.
These differ somewhat from the results of the SPDRL and LSTM;
in particular a few had high SmSEA ODs and low SmCTF ODs
(see ringed points in figure 9). Three of these points are the results
from patients with parasitologically-proven S. mansoni infection
(two of which gave negative SmCTF-ELISA results); the other is
not associated with any one infection species or status. Despite
these outlying results, there was 72.45% correlation (95% CI 54.4–
84.1; p,0.0001).
In contrast to the SPDRL’s results, the majority of individual
anti-SmSEA OD readings (mean= 0.534, SD=0.114) are greater
than the respective anti-SmCTF OD values (mean=0.365,
SD=0.152) for S. mansoni infection sera, a difference which is
significant (p = 0.0124). Also, in contrast to the results from the
SPDRL and LSTM (figures 4 and 5), the AMC found that 5 S.
haematobium-infection sera gave a higher mean OD reading with
SmCTF (mean= 0.49, SD=0.15) than 10 S. mansoni infection sera
(mean=0.36, SD=0.04), a difference that was significant
(p,0.05).
NMU
Sera from 42 subjects living in the vicinity of Poyang Lake,
Jiangxi Province, China, an area endemic for S. japonicum, and
from 20 volunteers with no history of living in a schistosome
endemic area were tested for reactivity in ELISA against 3
antigens: SmCTF, SmSEA and SjSEA, the last of these three
being the antigen routinely used to detect anti-S. japonicum
antibodies in this laboratory.
The individual OD450 results for the 3 groups of sera against the
3 different antigens are shown in Figure 10. The mean reactivities
of each of the 3 groups against each antigen are very similar. (Egg-
positives: SmSEA mean= 1.28, SD=0.20; SjSEA mean=1.29,
SD=0.20; SmCTF mean= 1.24, SD=0.22; egg negatives:
SmSEA mean=0.91, SD=0.24; SjSEA mean=0.91, SD=0.24;
SmCTF mean= 0.87, SD=0.26; negative controls: SmSEA
mean=0.37, SD=0.08; SjSEA mean= 0.35, SD=0.08; SmCTF
mean=0.37, SD=0.07). The 3 respective groups of sera gave very
similar OD450 values irrespective of whether an egg antigen
preparation from either S. japonicum (mean= 0.88, SD=0.44) or S.
mansoni (mean=0.88, SD=0.43), or the S. mansoni cercarial
antigen preparation (mean=0.85, SD=0.42) was the target in
ELISA. The correlation between the anti-SjSEA OD450 values
and the anti-SmCTF OD450 values was 96.6% (95% CI 94.2–
98.0; p,0.0001). There was 96.4% correlation between the anti-
SmSEA OD450 values and the anti-SmCTF OD450 values (95%
CI 94.0–97.9 (p,0.0001), and 98.5% correlation between the
anti-SjSEA OD450 values and the anti-SmSEA OD450 values (95%
CI 97.5–99.1; p,0.0001).
The OD450 values that discriminated between a +ve and 2ve
outcome for each serum in this experiment were calculated as the
mean+26 SD of the uninfected control OD450 values of the
uninfected sera. The cut-off values thus calculated were for:
SmSEA=0.539, SmCTF=0.498 and SjSEA=0.502. All three of
the antigens used in ELISA gave positive results on the sera from
egg-positive cases. Most of the sera from endemic egg-negative
cases tested positive with all three antigens in ELISA, i.e. gave
false-positive results compared to egg microscopy. All of the
negative controls gave negative ELISA results with the three
antigens, except for one which gave a false-positive result with
SjSEA.
Using SjSEA in ELISA as the ‘gold standard’ for diagnosis of S.
japonicum infection, SmCTF had 95.24% sensitivity and 100%
Figure 6. LSTM: correlation between S. mansoni cercarial transformation fluid (SmCTF) and soluble egg antigen (SmSEA) in ELISA.
Results for sera from patients infected with S. mansoni.
doi:10.1371/journal.pntd.0001815.g006
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specificity. The two ‘false-negatives’ seen were due to positive
results with SjSEA on a negative control and an egg-negative case.
SmSEA gave exactly the same positive and negative results as
SmCTF, and so also had 95.24% sensitivity and 100% specificity
compared to SjSEA. SmSEA and SmCTF had a positive
predictive value (PPV) of 100% and a negative predictive value
(NPV) of 90.9%.
Using egg microscopy as the gold standard, SmCTF had a
sensitivity of 100% and a specificity of 62.5%. 15/17 of the
endemic area egg-negative cases gave positive results with SmCTF
in ELISA. There were no false-negatives. SmSEA had the same
sensitivity and specificity values as SmCTF. SjSEA in ELISA
compared with egg microscopy had a sensitivity of 100% and was
59.5% specific; i.e., less specific than SmCTF and SmSEA as there
were 2 more false-positives using SjSEA. There were no false-
negatives. SmSEA and SmCTF had a PPV of 62.5% and a NPV
of 100%; SjSEA had a PPV of 59.5% and a NPV of 100%.
A flow-chart summarizing the results from the 5 laboratories is
given in supporting information Figure S1.
Discussion
The above results indicate that in three different laboratory
settings the novel SmCTF antigen preparation is as effective in
detecting anti-S. mansoni, anti-S. haematobium and anti-S. japonicum
antibodies as SmSEA. The latter antigenic preparation, derived
from S. mansoni eggs, has been routinely used to diagnose
schistosome infections in the 3 European laboratories participating
in this study, all of which have diagnostic service responsibilities.
There were some minor differences between the 3 European
laboratories, perhaps a reflection of the way that each performs its
ELISA reactions and incidentally an indication that there is as yet
no standardized and widely used method for detecting anti-
schistosome antibodies.
The results from the SPDRL show that for the suspected S.
mansoni-infection sera the sensitivity of SmCTF relative to SmSEA
is high with only one false-negative in 59 results. Specificity is not
so high: 80% as a result of 5 false-positives, but this could be due to
failure of the SmSEA to detect light infections [3]. It could
however alternatively be due to sensitisation by cercarial antigens
of bird and animal schistosome species, though an association
between these and the White Nile in Uganda has seldom if ever
been reported. Indeed, cross-reactivity between SmCTF and
antibodies from cercarial dermatitis patients will need to be
investigated before this assay is fully validated.
For the S. haematobium-infection sera examined in SPDRL
SmCTF was 100% sensitive and 100% specific as there were no
false-negatives or false-positives relative to SmSEA.
The AMC results differed from those of the other two European
laboratories since those infection sera with higher SmSEA OD
readings had lower SmCTF OD readings and three of them were
Figure 7. LSTM: correlation between S. mansoni cercarial transformation fluid (SmCTF) and soluble egg antigen (SmSEA) in ELISA.
Results for sera from patients infected with S. haematobium.
doi:10.1371/journal.pntd.0001815.g007
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Figure 8. LSTM: correlation between S. mansoni cercarial transformation fluid (SmCTF) and soluble egg antigen (SmSEA) in ELISA.
Results for sera from patients suspected to be infected with schistosomes, but not identifiable as either S. mansoni or S. haematobium.
doi:10.1371/journal.pntd.0001815.g008
Figure 9. AMC: correlation between S. mansoni cercarial transformation fluid (SmCTF) and soluble egg antigen (SmSEA) in ELISA.
Results for sera from a total of 46 subjects: 21 from patients with parasitologically-proven schistosome infections, 20 sera that were positive in routine
serology and 5 negative controls. %= sera from patients known to be S. mansoni-infected; #= sera from patients known to be S. haematobium-
infected; &= sera from patients with Katayama fever; N= sera from patients that tested positive for schistosomiasis in routine serology, but were
egg-negative; m= control negative sera from patients that tested negative in routine serology.
doi:10.1371/journal.pntd.0001815.g009
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parasitologically-proven S. mansoni-infection sera. Two of these
gave false-negative results. The sample size here was, however,
considerably smaller than that of the other two laboratories with
only 10 S. mansoni-infection sera tested.
At the SPDRL, SmCTF gave higher OD readings with S.
mansoni-infection sera than SmSEA (p,0.05), but this was not the
case in the other two laboratories; the LSTM’s results showed little
distinction between SmCTF and SmSEA with regard to the OD
values given by individual sera in ELISA, and at the AMC SmSEA
gave higher OD readings than SmCTF with S. mansoni infection
sera (p,0.02). Again there is the problem of a small sample size
with the results from the AMC.
It is perhaps surprising that the S. haematobium-infection sera
reacted well with the S. mansoni antigen preparations in all three
laboratories, both cercarial-derived (SmCTF) and egg-derived
(SmSEA). At the AMC they reacted better with SmCTF than the
S. mansoni-infection sera (p,0.05), but at the LSTM S. mansoni sera
reacted better than S. haematobium sera (p,0.02) and there was no
significant difference between the two at the SPDRL.
It has long been known that anti-cercarial antibodies in human
infection sera can be demonstrated, for example by means of the
so-called cercarienhu¨llen reaction [33], but schistosome cercariae
have not often been used to detect antibodies in immunodiagnosis
of schistosomiasis, perhaps because of a relative lack of sensitivity
and specificity [3,34]. Higher anti-larval:anti-adult antibody levels
may be useful in discriminating between acute and chronic
infection [35]. Two more recent studies have indicated that the
novel cercarial antigen SmCTF performs equivalently to SmSEA
for the diagnosis of both S. mansoni and S. haematobium infections
[27,28].
It is suspected that the anti-schistosome antibodies that
were detected by the SmCTF-ELISA had been induced by
immunogens derived from eggs lodged in the tissues of infected
humans (rather than by the schistosome cercariae or worms that
caused the infection). Furthermore, the carbohydrate molecules
derived from the cercarial glycocalyx and which become
solubilised during the transformation of cercariae to schistosomula
are suspected to be the principal antigenic moiety in SmCTF
reactive here in ELISA. The serological cross-reactivity indicated
by the present results, both between schistosome species and
between antigens derived from schistosome cercarial and egg
stages, is likely to be due to the presence of the same carbohydrate
epitopes on the molecular constituents of eggs and larvae of the
different species [22,23,36–38]. In view of the likely high
dependence of the anti-cercarial antigen antibody reactivity being
induced by egg antigens, it seems improbable that SmCTF will be
of use in detecting pre-patent or single-sex worm-alone infections.
It seems to us less likely that protein epitopes are involved to any
significant extent in the antigen/antibody reactions described here
because the reactivity of human infection sera against SmCTF in
Western immunoblots is negated by prior treatment of the
antigens with sodium metaperiodate solution (Francklow and
Doenhoff, unpublished result). Furthermore, antibodies reactive
against one of the principal protein constituents of SmCTF, the
cercarial elastase, seem not to be present in human infection sera
[39].
Many of the schistosome-infected subjects encountered by the
three European laboratories involved in this study during the
course of their diagnostic service responsibilities have light levels of
infection which routine parasitological microscopy and antigen-
detection methods often are too insensitive to detect. Despite their
disadvantages, antibody-detection methods have therefore to be
resorted to in the absence of any other useful test to detect
infection directly. Because it is such a safe drug, praziquantel is
Figure 10. NMU: reactivity of sera from the Peoples Republic of China against S. mansoni SEA (SmSEA), S. japonicum SEA (SjSEA) and
S. mansoni CTF (SmCTF) in ELISA. Twenty five sera were from S. japonicum egg-positive subjects and 17 from egg-negative subjects, both groups
living in an area endemic for schistosomiasis japonicum, and 20 sera from negative controls living outwith an endemic area. Horizontal lines indicate
the mean OD450 values for each antigen in each of the subject groups. N SmSEA & SjSEA m SmCTF.
doi:10.1371/journal.pntd.0001815.g010
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then often automatically administered to those who are antibody-
positive, despite a risk of some of the antibody-detection diagnostic
test results being falsely-positive with regard to active infection.
Praziquantel has become the basis for control of endemic
schistosomiasis and has begun to be used on a large scale in mass
drug-administration programmes [40–43]. Microscopical parasi-
tology, particularly the Kato-Katz method, has generally been
used to estimate epidemiological parameters prior to commence-
ment of these control programmes. If, however, control is
successful the rate of schistosome egg excretion will decline in
treated populations and Kato-Katz is likely to become ever less
useful due to its relative insensitivity [3,11,17,34]. In the absence
of effective alternative methods to detect schistosome infections
directly it is now being anticipated that antibody detection
methods will become increasingly useful [17]. The importance of
developing novel diagnostic tools appropriate to the changing
requirements of control programmes is now becoming widely
recognised, despite this research area often being thought of as less
important than that of others, such as drug and vaccine
development [11,43,44].
Stothard has recently evaluated the potential of diagnostic tests
in improving control of schistosomiasis [45] and SmSEA in the
ELISA format has been shown to hold promise as a diagnostic
method for the monitoring of this disease in Zanzibar [46]. SEA-
ELISA tests are the frequent method of choice in travellers’
medicine clinics [18] and there is also a commercially-produced
SmSEA-ELISA kit now available for use in the field [46]. Indeed,
SEA-ELISA formats have previously given meaningful results in
endemic areas [21,47]. The production of egg antigens is however
a fairly laborious and expensive process as the eggs have to be
produced from infected animals. The use of SmCTF as a
replacement for SmSEA would be a cost-effective option as
SmCTF is harvested from infected snails, which are relatively easy
to culture and maintain. This would also reduce the number of
mice that are required, in comparison to those needed for the
production of SmSEA. We estimate the overall animal-usage costs
of producing SmCTF to be as much as 90% less than to produce
an equivalent antigenic biomass from eggs.
As well as the expense of SmSEA, use of ELISA is also
problematic outside the laboratory because of power requirements
for blood centrifugation and electronic reading of ODs. Point-of-
care (POC) or rapid diagnostic tests (RDTs) that are scalable and
cost-effective for use in the developing world are becoming
increasingly useful for the diagnosis of helminth infections [11].
RDTs that work on whole blood are likely to be useful for the
implementation of control programmes in countries endemic for
schistosomiasis, provided their application improves the efficiency
of allocating praziquantel treatments and their costs can thus be
off-set at least in part by a reduction in drug-wastage as a result of
those who are antibody-negative being left untreated [45]. As the
SmCTF antigen is cheap to produce and appears to be as good as
SmSEA in these preliminary experiments and others [27,28], a
rapid test incorporating SmCTF to detect anti-schistosome
antibodies, in a format usable with whole blood as well as serum,
is being developed. It is hoped that it can be produced for sale at a
cost of ,US$1.00 which would make its use for control of
schistosomiasis in endemic areas economically justified [45]. Of
course such an assay would need to be evaluated in endemic areas
prior to implementation.
There is currently a commercially available RDT on the market
for diagnosis of both intestinal and urinary schistosomiasis by
detection of circulating antigens (marketed by Rapid Medical
Diagnostics, South Africa), but this test has recently been shown to
be unsatisfactory for diagnosis of S. haematobium infections in
Zanzibar [46,48], despite being a reformulation of a test that
encountered problems previously. The circulating cathodic
antigen (CCA) urine-dipstick was however found to be an effective
means of testing for intestinal schistosomiasis in shoreline
communities of Lake Victoria [49].
Because the CCA-RDT has been marketed at US$2.3–2.8 per
test [49], and more recently at $1.98 [50], an RDT using
SmCTF to detect anti-schistosome antibodies would be a more
cost-effective alternative, with great benefits to endemic areas, as
many are resource-poor. As the results above indicate SmCTF is
as good as SmSEA in detecting anti-schistosome antibodies in
ELISA and thus decidedly a promising technique for the
diagnosis and monitoring of schistosomiasis. Our results also
show that SmCTF reacts well with both S. mansoni and S.
haematobium infection sera, an advantage over the urine-CCA
strips currently on the market.
Definitive diagnosis of schistosomiasis japonica is still very
reliant on the demonstration of viable ova in faeces or other
histological samples, despite the fact that parasitological tech-
niques have now become relatively insensitive following wide-
spread, repeated chemotherapy [51]. Immunodiagnostic technol-
ogy was incorporated into the national control program in China
in the 1980s as a way of improving identification of individuals as
targets for treatment [52]. The Chinese national control program
recommends the use of immunodiagnostic assays for the screening
of populations in schistosome-endemic areas with a prevalence of
less than 20% [53]. Immunodiagnosis is also used for preliminary
screening in areas where the prevalence rate is less than 5% [52].
Among the techniques that have been successfully applied in the
field is the ELISA incorporating S. japonicum soluble egg antigens
(SjSEA) for detection of the anti-schistosome antibodies. The assay
has high sensitivity and good specificity in diagnosis of S. japonicum
infections [53–55], but the same problems as those with the
SmSEA-ELISA are encountered: SjSEA is expensive to produce,
there is the problem of requiring sera for ELISA and the ELISA
format is generally not suitable for use outside of a designated
laboratory. The results here show that SmCTF performs
equivalently to SjSEA in ELISA with S. japonicum infection sera.
This suggests not only that SmCTF could replace SjSEA in ELISA
for diagnosis of S. japonicum infections, but also that an RDT
incorporating SmCTF for diagnosis of S. mansoni and S.
haematobium infections could have potential in the diagnosis of
schistosomiasis japonica.
In conclusion, the SmCTF antigen appears to perform
equivalently to SmSEA in ELISA with S. mansoni and S.
haematobium infection sera, as well as with S. japonicum sera. SmCTF
is more easily and cheaply produced than SmSEA, with the added
advantage of a reduced number of laboratory animals required for
antigen production. As well as replacing SmSEA in ELISA, the
SmCTF could have potential in the development of an RDT that
detects anti-schistosome antibodies in whole blood-usable format.
If this RDT could be marketed at ,US$1.00 per test its
application in schistosomiasis control programmes in endemic
areas would seemingly be justified. Development and evaluation of
a RDT incorporating SmCTF as the antibody target is now
underway.
Supporting Information
Figure S1 A flow-chart summarizing the number of sera
tested for reactivity against SmSEA and SmCTF in ELISA
in the 5 laboratories, and the outcome in terms of
number of sera giving positive and negative reactions.
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